These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22304703)

  • 1. Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique.
    Chen Z; Lu Y; Qi J; Wu W
    Pharm Dev Technol; 2013 Feb; 18(1):130-6. PubMed ID: 22304703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.
    Zhang X; Wu D; Lai J; Lu Y; Yin Z; Wu W
    J Pharm Sci; 2009 Feb; 98(2):665-75. PubMed ID: 18543294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.
    Lu Y; Guo T; Qi J; Zhang J; Wu W
    AAPS PharmSciTech; 2012 Dec; 13(4):1222-9. PubMed ID: 22968546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
    Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
    Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
    Garnero C; Aiassa V; Longhi M
    J Pharm Biomed Anal; 2012 Apr; 63():74-9. PubMed ID: 22361661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B; Zhong S; Li N; Li X; Yi J; Jin M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and dissolution enhancement of mefloquine hydrochloride-betaCD inclusion complex.
    Patil SS; Patil AL
    Pharmazie; 2011 Jun; 66(6):416-20. PubMed ID: 21699079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
    Desai D; Kothari S; Huang M
    Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
    Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
    Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
    Yap KL; Liu X; Thenmozhiyal JC; Ho PC
    Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.
    Asbahr AC; Franco L; Barison A; Silva CW; Ferraz HG; Rodrigues LN
    Bioorg Med Chem; 2009 Apr; 17(7):2718-23. PubMed ID: 19282187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.